Advanced Hybrid Closed-Loop in T1D
Key messages
- The automated Advanced Hybrid Closed-Loop system was effective in reducing mean HbA1c even in a well-controlled population of patients with type 1 diabetes.
- No safety or device related issues were found in this 90-day trial.